Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Hacking-Risk Allegations: US FDA Continues Assessment, As Firm Files Lawsuit

Executive Summary

While conflicting reports have surfaced regarding the veracity of allegations from a short-seller that a significant number of St. Jude cardiac rhythm management devices have serious cybersecurity flaws, FDA says plans to complete an initial assessment of the allegations soon. The Minnesota device-maker, meanwhile, says it is suing the short-seller for disseminating false information.

You may also be interested in...



Multiple Hacking Risks Found In Another Infusion Pump

After a hacker brought the issue to the attention of Smiths Medical, the company engaged US FDA and the Department of Homeland Security, which alerted users that Smith's Medfusion 4000 wireless syringe infusion pumps are at risk from multiple cybersecurity vulnerabilities.

FDA Recommends Security Patch For St. Jude Wireless Cardiac Devices

Following months of bickering between St. Jude and Muddy Waters Research, US FDA issued a safety alert for the device-maker's wireless cardiac devices. The agency says there's a risk for malicious cyber-attacks and recommends a software patch to minimize risk.

Lawmakers Question FDA On Medical Device Cybersecurity Concerns

Top lawmakers on the House Energy and Commerce Committee wrote to US FDA asking what the agency is doing to ensure devices are protected against malicious hackers.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel